Ratings IDI

Equities

IDIP

FR0000051393

Market Closed - Euronext Paris Other stock markets 11:35:29 2024-04-26 am EDT			5-day change	1st Jan Change
74.8 ^EUR	+0.54%		0.00%	+10.98%

Apr. 09	IDI: acquisition of a majority stake in Exsto	CF
Apr. 08	IDI acquired an unknown majority stake in EXSTO SAS.	CI

Strengths

Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
The company is one of the best yield companies with high dividend expectations.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

The company's earnings growth outlook lacks momentum and is a weakness.
The company's "enterprise value to sales" ratio is among the highest in the world.

Ratings chart - Surperformance

Sector: Investment Management & Fund Operators

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
IDI	+10.98%	569M		-
PARTNERS GROUP HOLDING AG	-1.48%	33.94B		B
EQT AB	+3.65%	31.94B		B
CVC CAPITAL PARTNERS PLC	0.00%	17.45B	-	-
ONEX CORPORATION	+6.42%	5.54B	-	C
CORPORACIÓN FINANCIERA ALBA, S.A.	-0.42%	3.08B	-	B-
GOLUB CAPITAL BDC, INC.	+15.23%	2.98B		D+
PETERSHILL PARTNERS PLC	+22.64%	2.9B		C-
BRIDGEPOINT GROUP PLC	-18.98%	2.24B		C+
INVESTCORP CAPITAL PLC	+4.02%	1.23B	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes